Screener
Ironwood Pharmaceuticals IRWD Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's current ratio?
- Ironwood Pharmaceuticals (IRWD) reported current ratio of 6.1× in Q2 2026.
- How has Ironwood Pharmaceuticals's current ratio changed year-over-year?
- Ironwood Pharmaceuticals's current ratio increased by 635.2% year-over-year, from 0.8× to 6.1×.
- What is the long-term trend for Ironwood Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's current ratio has grown at a -40.7% compound annual growth rate (CAGR), from 15.4× to 1.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Ironwood Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude